Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2025-12-01
2028-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The new Italian forensic treatment model is essentially community-based, exclusively managed by the health system, with rehabilitation and recovery purposes in the patient's home territory. Due to its characteristics, it is unique in the Western world.
In California, the forensic treatment model is defined by the California Penal Code. The Department of State Hospitals (DSH) oversees the care and security pathways of individuals deemed not criminally responsible by reason of mental disorder (NGRI) or incompetent to stand trial (IST). Care pathways are organized around the secure hospital, with the largest number of beds in high-security hospitals. There are also community-based forensic facilities. The average length of stay is 10 years, two-thirds of which is in the hospital.
The forensic treatment models of the two countries considered are, therefore, very different from each other, each with specific strengths and weaknesses.
Some national data (Catanesi et al, 2019) show that the length of stay in Italian community forensic facilities intended to exclusively accommodate people subject to detention security measures (Residences for the Execution of the Security Measure = REMS) is much shorter than in California.
Furthermore, REMS do not have the same standardization of safety procedures to be followed that is observed in Californian hospitals, whether it concerns structural measures, relational measures, or professional services. There is instead a greater use of psychotherapeutic treatments and rehabilitative and occupational activities. Some experiential data seem to indicate, however, some specific outcome indicators in REMS that suggest greater forensic treatment efficacy compared to Californian forensic hospital facilities.
The differences between the two countries raise important questions about the clinical, therapeutic, and social factors that may be relevant in the forensic recovery process. Understanding the nature of these questions may illustrate a more generalizable understanding of the factors that help people receiving forensic care recover and regain successful social reintegration in a safe manner. Understanding the similarities and contrasts between the two different treatment settings of California and Italy is the primary goal of this study.
Despite the diversity of the forensic models of the two countries considered, we intend to compare the two different treatment realities by enrolling a national sample of Italian forensic patients (Group I) and a sample of forensic patients from the State of California (Group C) of equal numbers, to then follow them both for three years with annual check-ups. Starting from a similar starting time T0 for both patient samples, using the same risk assessment and clinical tools, the same data collection form common to the models of the two countries (containing personal, work, anamnestic, clinical, and judicial data) and a specific treatment evaluation form (quality and type of pharmacological treatment; level of adherence to pharmacological treatment; awareness of the disease and level of adaptation to the treatment measures; quality of the rehabilitation measures chosen; any psychotherapies; family support during the project; commitment to socially useful or work-related activities; economic support), the enrolled patients will be followed for three years starting from time T0 through annual periodic check-ups.
The admission criteria differ between the Californian and Italian systems. However, some patients are similar in diagnosis and type of crime committed. Focusing on patients with similar diagnoses and type of crime committed will allow us to understand the differences that we expect to observe in the different care models. Therefore, for the purposes of comparison, we will focus on patients with diagnoses of psychotic disorder and mental disorder with respect to the crime committed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Excellence in Italy's Residence for Execution of Security Measure
NCT06018298
Biocriminology and the Adjudication of Criminal Responsibility: Is There a Consensus Among Scientists' Verdicts?
NCT05007314
Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.
NCT05939765
CRacking the HEterogeneity of Social Outcome Through Neuropsychophysiological Profiles
NCT06869616
Multidisciplinary Rehabilitation Program for Treatment-Resistant Psychotic Forensic Patients: A Comparative Study
NCT07183982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For Group I, ex lege reference will be made both to REMS, in the case of custodial security measures, and to other care settings (residential, semi-residential, domicile), in the case of non-custodial security measures. As far as the type of security measure is concerned, both definitive and provisional measures will be considered.
The observation period will be three years from the recruitment period to the target date (time = T0).
All patients will be asked to give written informed consent to participate in the research, in full compliance with the ethical and deontological principles provided; if subject to forms of legal guardianship, the guardian or the Support Administrator will be involved.
Patients in Groups I and C will be monitored for three years from their enrolment with annual check-ups: at twelve months (T1); at twenty-four months (T2); at thirty-six months (T3) or upon discharge from the forensic system, depending on whether this occurs before the expected observation time. At the end of the three years of observation, a structured interview with the Clinical Global Impression - Change (CGI-C) will be conducted with the health workers involved to record their subjective perception of the quality of treatment offered to patients. At the time of discharge, information will be acquired on the patient's subsequent placement and whether discharge is conditional or not. In the event of discharge from the facility involved before the three years of observation expected, the patient, at the time of discharge, will be subjected to the subsequent verification expected with respect to the last one actually carried out, with the same tools provided for by the research protocol. In this case too, the CGI-C will be carried out with the reference health workers, and information will be acquired on the patient's subsequent placement and whether discharge is conditional or not.
The evaluation procedures planned at times T1, T2, and T3 on the enrolled patients must be carried out in a limited period of time (max 2 weeks), the same for all.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Italian forensic patients
Italian forenisc patients
No interventions assigned to this group
Californian Forensic patients
Californian forensic patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Felice Carabellese
MD Full Professor in Forensic Psychiatry
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REMS FEIFT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.